IFN-beta improves BCG immunogenicity by acting on DC maturation.

Elena Giacomini1, Maria Elena Remoli, Valérie Gafa

  • 1Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy.

Summary

New research shows that adding interferon-beta (IFN-beta) to dendritic cells (DC) infected with Mycobacterium bovis bacillus Calmette-Guérin (BCG) enhances their ability to stimulate a protective immune response, suggesting IFN-beta as a potential vaccine adjuvant for tuberculosis.